Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Diagnostic Nuclear Drug
1.2 Key Market Segments
1.2.1 Diagnostic Nuclear Drug Segment by Type
1.2.2 Diagnostic Nuclear Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Diagnostic Nuclear Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Diagnostic Nuclear Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Diagnostic Nuclear Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Diagnostic Nuclear Drug Market Competitive Landscape
3.1 Global Diagnostic Nuclear Drug Sales by Manufacturers (2019-2025)
3.2 Global Diagnostic Nuclear Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Diagnostic Nuclear Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Diagnostic Nuclear Drug Sales Sites, Area Served, Product Type
3.6 Diagnostic Nuclear Drug Market Competitive Situation and Trends
3.6.1 Diagnostic Nuclear Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Diagnostic Nuclear Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Diagnostic Nuclear Drug Industry Chain Analysis
4.1 Diagnostic Nuclear Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Diagnostic Nuclear Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Diagnostic Nuclear Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diagnostic Nuclear Drug Sales Market Share by Type (2019-2025)
6.3 Global Diagnostic Nuclear Drug Market Size Market Share by Type (2019-2025)
6.4 Global Diagnostic Nuclear Drug Price by Type (2019-2025)
7 Diagnostic Nuclear Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diagnostic Nuclear Drug Market Sales by Application (2019-2025)
7.3 Global Diagnostic Nuclear Drug Market Size (M USD) by Application (2019-2025)
7.4 Global Diagnostic Nuclear Drug Sales Growth Rate by Application (2019-2025)
8 Diagnostic Nuclear Drug Market Consumption by Region
8.1 Global Diagnostic Nuclear Drug Sales by Region
8.1.1 Global Diagnostic Nuclear Drug Sales by Region
8.1.2 Global Diagnostic Nuclear Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Diagnostic Nuclear Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Diagnostic Nuclear Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Diagnostic Nuclear Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Diagnostic Nuclear Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Diagnostic Nuclear Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Diagnostic Nuclear Drug Market Production by Region
9.1 Global Production of Diagnostic Nuclear Drug by Region (2019-2025)
9.2 Global Diagnostic Nuclear Drug Revenue Market Share by Region (2019-2025)
9.3 Global Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Diagnostic Nuclear Drug Production
9.4.1 North America Diagnostic Nuclear Drug Production Growth Rate (2019-2025)
9.4.2 North America Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Diagnostic Nuclear Drug Production
9.5.1 Europe Diagnostic Nuclear Drug Production Growth Rate (2019-2025)
9.5.2 Europe Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Diagnostic Nuclear Drug Production (2019-2025)
9.6.1 Japan Diagnostic Nuclear Drug Production Growth Rate (2019-2025)
9.6.2 Japan Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Diagnostic Nuclear Drug Production (2019-2025)
9.7.1 China Diagnostic Nuclear Drug Production Growth Rate (2019-2025)
9.7.2 China Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Cardinal Health
10.1.1 Cardinal Health Diagnostic Nuclear Drug Basic Information
10.1.2 Cardinal Health Diagnostic Nuclear Drug Product Overview
10.1.3 Cardinal Health Diagnostic Nuclear Drug Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health Diagnostic Nuclear Drug SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Diagnostic Nuclear Drug Basic Information
10.2.2 GE Healthcare Diagnostic Nuclear Drug Product Overview
10.2.3 GE Healthcare Diagnostic Nuclear Drug Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare Diagnostic Nuclear Drug SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Curium Pharma
10.3.1 Curium Pharma Diagnostic Nuclear Drug Basic Information
10.3.2 Curium Pharma Diagnostic Nuclear Drug Product Overview
10.3.3 Curium Pharma Diagnostic Nuclear Drug Product Market Performance
10.3.4 Curium Pharma Diagnostic Nuclear Drug SWOT Analysis
10.3.5 Curium Pharma Business Overview
10.3.6 Curium Pharma Recent Developments
10.4 Jubilant Pharma
10.4.1 Jubilant Pharma Diagnostic Nuclear Drug Basic Information
10.4.2 Jubilant Pharma Diagnostic Nuclear Drug Product Overview
10.4.3 Jubilant Pharma Diagnostic Nuclear Drug Product Market Performance
10.4.4 Jubilant Pharma Business Overview
10.4.5 Jubilant Pharma Recent Developments
10.5 Bracco Imaging
10.5.1 Bracco Imaging Diagnostic Nuclear Drug Basic Information
10.5.2 Bracco Imaging Diagnostic Nuclear Drug Product Overview
10.5.3 Bracco Imaging Diagnostic Nuclear Drug Product Market Performance
10.5.4 Bracco Imaging Business Overview
10.5.5 Bracco Imaging Recent Developments
10.6 Novartis
10.6.1 Novartis Diagnostic Nuclear Drug Basic Information
10.6.2 Novartis Diagnostic Nuclear Drug Product Overview
10.6.3 Novartis Diagnostic Nuclear Drug Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 SIEMENS
10.7.1 SIEMENS Diagnostic Nuclear Drug Basic Information
10.7.2 SIEMENS Diagnostic Nuclear Drug Product Overview
10.7.3 SIEMENS Diagnostic Nuclear Drug Product Market Performance
10.7.4 SIEMENS Business Overview
10.7.5 SIEMENS Recent Developments
10.8 China Isotope and Radiation
10.8.1 China Isotope and Radiation Diagnostic Nuclear Drug Basic Information
10.8.2 China Isotope and Radiation Diagnostic Nuclear Drug Product Overview
10.8.3 China Isotope and Radiation Diagnostic Nuclear Drug Product Market Performance
10.8.4 China Isotope and Radiation Business Overview
10.8.5 China Isotope and Radiation Recent Developments
10.9 Dongcheng
10.9.1 Dongcheng Diagnostic Nuclear Drug Basic Information
10.9.2 Dongcheng Diagnostic Nuclear Drug Product Overview
10.9.3 Dongcheng Diagnostic Nuclear Drug Product Market Performance
10.9.4 Dongcheng Business Overview
10.9.5 Dongcheng Recent Developments
10.10 Lantheus
10.10.1 Lantheus Diagnostic Nuclear Drug Basic Information
10.10.2 Lantheus Diagnostic Nuclear Drug Product Overview
10.10.3 Lantheus Diagnostic Nuclear Drug Product Market Performance
10.10.4 Lantheus Business Overview
10.10.5 Lantheus Recent Developments
10.11 Eli Lilly
10.11.1 Eli Lilly Diagnostic Nuclear Drug Basic Information
10.11.2 Eli Lilly Diagnostic Nuclear Drug Product Overview
10.11.3 Eli Lilly Diagnostic Nuclear Drug Product Market Performance
10.11.4 Eli Lilly Business Overview
10.11.5 Eli Lilly Recent Developments
11 Diagnostic Nuclear Drug Market Forecast by Region
11.1 Global Diagnostic Nuclear Drug Market Size Forecast
11.2 Global Diagnostic Nuclear Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Diagnostic Nuclear Drug Market Size Forecast by Country
11.2.3 Asia Pacific Diagnostic Nuclear Drug Market Size Forecast by Region
11.2.4 South America Diagnostic Nuclear Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Diagnostic Nuclear Drug by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Diagnostic Nuclear Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Diagnostic Nuclear Drug by Type (2025-2032)
12.1.2 Global Diagnostic Nuclear Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Diagnostic Nuclear Drug by Type (2025-2032)
12.2 Global Diagnostic Nuclear Drug Market Forecast by Application (2025-2032)
12.2.1 Global Diagnostic Nuclear Drug Sales (K MT) Forecast by Application
12.2.2 Global Diagnostic Nuclear Drug Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
